XB
Xebra Brands Ltd.
XBRAF · OTC
$0.00 +0.00% (+$0.00)
1M -99.00%
Market Cap $2.16K
P/E Ratio -
Div. Yield -
ROE 2,092.28%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.04x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
40 /100
Average ROE 2,092.28%
ROA 455.46%
Asset turnover 0.00x
Debt
68 /100
Low Current ratio 0.46x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 173.23%
Profitable years 0
Beta -3.09x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o XBRAF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rodrigo Valencia Gallardo
Employees
2
Headquarters
Vancouver